Synchron has been published in multiple peer-reviewed journals including JAMA Neurology, Nature Biotechnology, Nature Biomedical Engineering, and JNIS. Synchron is based in Brooklyn, New York with R&D ...

- A patient with ALS in the United States is the first person in the world to use Amazon Alexa via an implantable brain computer interface to interact with and control his environment. NEW ...

Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego Synchron, a leader in non-surgical brain-computer interface ...

An overview of Synchron's BCI system and how it allows users with motor impairment to control their digital devices. (Image credit: Synchron) At GTC 2025, Synchron demonstrated how its AI-enabled BCI, ...

Medical device leaders who have built and scaled category-defining products join Synchron to help drive its next-generation brain-computer interface platform as well as accelerate towards ...

NEW YORK, January 13, 2025--(BUSINESS WIRE)--Synchron, a category-defining brain-computer interface (BCI) company, announced today a step forward in implantable BCI technology to drive the future of ...

Neurotech firm Synchron has integrated OpenAI’s generative AI tech into its brain-computer interface to help severely paralyzed patients communicate again. Patients suffering from severe neurological ...

Synchron, a brain-computer interface (BCI) company, has unveiled the roadmap to Chiral, which the company describes as “a foundation model of human cognitions, marking the emergence of Cognitive AI.” ...